A new trading day began on Tuesday, with ProMIS Neurosciences Inc (NASDAQ: PMN) stock price down -4.44% from the previous day of trading, before settling in for the closing price of $0.7. PMN’s price has ranged from $0.38 to $1.59 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -628.60%. With a float of $20.22 million, this company’s outstanding shares have now reached $32.69 million.
Let’s determine the extent of company efficiency that accounts for 7 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
ProMIS Neurosciences Inc (PMN) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of ProMIS Neurosciences Inc is 38.15%, while institutional ownership is 24.26%. The most recent insider transaction that took place on Feb 10 ’25, was worth 14,595. In this transaction Chief Scientific Officer of this company bought 15,000 shares at a rate of $0.97, taking the stock ownership to the 16,617 shares. Before that another transaction happened on Sep 24 ’24, when Company’s Director bought 70,000 for $1.30, making the entire transaction worth $91,028. This insider now owns 208,333 shares in total.
ProMIS Neurosciences Inc (PMN) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -628.60% per share during the next fiscal year.
ProMIS Neurosciences Inc (NASDAQ: PMN) Trading Performance Indicators
Here are ProMIS Neurosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.36.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.04, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.52 in one year’s time.
Technical Analysis of ProMIS Neurosciences Inc (PMN)
Looking closely at ProMIS Neurosciences Inc (NASDAQ: PMN), its last 5-days average volume was 0.8 million, which is a drop from its year-to-date volume of 2.97 million. As of the previous 9 days, the stock’s Stochastic %D was 7.89%.
During the past 100 days, ProMIS Neurosciences Inc’s (PMN) raw stochastic average was set at 23.97%, which indicates a significant increase from 21.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1580 in the past 14 days, which was higher than the 0.0802 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5673, while its 200-day Moving Average is $0.7628.
